Scientific study
Ended Definitive Contract Awarded Last action
- Contract number
- HHSF223201610125C
- Awardee
-
QPS LLC UEI P2F8FYL11D41
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $597,340
Award facts
- Opportunity
-
- FDABAA1600122 Solicitation number
- Food and Drug Administration Broad Agency Announcement for the Advanced Research and Development of Regulatory Science Award Notice · Posted Feb 23, 2016
- Contract value 100% obligated
- $597,340.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 67 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Newark, DE, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $597,340 |
About this award
This is a $597,340.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA) to QPS LLC, a minority-owned limited liability company, for a scientific study related to the assessment of in vitro percutaneous absorption, in vitro rate of release, and physicochemical properties. The contract does not have a set-aside designation, indicating it was an open market procurement. QPS LLC is an experienced federal contractor, having been awarded multiple contracts and task orders by various health research agencies, including the National Institute of Neurological Disorders and Stroke, the National Heart Lung and Blood Institute, and the National Center for Advancing Translational Sciences, for specialized laboratory testing and analysis services. This contract with the FDA is for work to be completed by December 31, 2019.
Quick answers
Who was awarded contract HHSF223201610125C?
HHSF223201610125C was awarded to QPS LLC by Food and Drug Administration (Department of Health and Human Services) on September 16, 2016.
How much is contract HHSF223201610125C worth?
The government has obligated $597,340 on HHSF223201610125C.
Was contract HHSF223201610125C competed?
The extent of competition for HHSF223201610125C was full and open competition. The government received 67 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award